Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm(3)

BACKGROUND: Antiretroviral therapy (ART) with a generic fixed-dose combination (FDC) of stavudine (d4T)/lamivudine (3TC)/nevirapine (NVP) is widely used in developing countries. The clinical data of this FDC among very advanced HIV-infected patients is limited. METHODS: A retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Manosuthi, Weerawat, Chimsuntorn, Sukanya, Likanonsakul, Sirirat, Sungkanuparph, Somnuek
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828738/
https://www.ncbi.nlm.nih.gov/pubmed/17352834
http://dx.doi.org/10.1186/1742-6405-4-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828738/
https://www.ncbi.nlm.nih.gov/pubmed/17352834
http://dx.doi.org/10.1186/1742-6405-4-6

Ejemplares similares